John Bs Booth

John Bs Booth

Auto-generated profile, based on publicly available information

John Bs Booth

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Hypertension
Verified
Journal Article
Closed access
PDF file
DCDavid A. Calhoun
David A. Calhoun
JBJohn N. Booth
John N. Booth
SOSuzanne Oparil
Suzanne Oparil
MIMarguerite R. Irvin
Marguerite R. Irvin
DSDaichi Shimbo
Daichi Shimbo
PMPaul Muntner
Paul Muntner
Refractory hypertension is an extreme phenotype of antihypertensive treatment failure. Participants in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, a large (n=30 239), population-based cohort were evaluated to determine the prevalence of refractory hypertension and associated cardiovascular risk factors and comorbidities. Refractory hypertension was defined as uncontrolled blood pressure (systolic/diastolic, ≥140/90 mm Hg) on ≥5 antihypertensive drug classes. Participants with resistant hypertension (systolic/diastolic, ≥140/90 mm Hg on ≥3 or <140/90 mm Hg on ≥4 antihypertensive classes) and all participants treated for hypertension served as comparator groups. Of 14 809 REGARDS participants receiving antihypertensive treatment, 78 (0.5%) had refractory hypertension. The prevalence of refractory hypertension was 3.6% among participants with resistant hypertension (n=2144) and 41.7% among participants on ≥5 antihypertensive drug classes. Among all participants with hypertension, black race, male sex, living in the stroke belt or buckle, higher body mass index, lower heart rate, reduced estimated glomerular filtration rate, albuminuria, diabetes mellitus, and history of stroke and coronary heart disease were associated with refractory hypertension. Compared with resistant hypertension, prevalence ratios for refractory hypertension were increased for blacks (3.00; 95% confidence interval, 1.68–5.37) and those with albuminuria (2.22; 95% confidence interval, 1.40–3.52) and diabetes mellitus (2.09; 95% confidence interval, 1.32–3.31). The median 10-year Framingham risk for coronary heart disease and stroke was higher among participants with refractory hypertension when compared with those with either comparator group. These data indicate that although resistant hypertension is relatively common among treated patients with hypertension, true antihypertensive treatment failure is rare.

1 June 2014 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
MIMarguerite Irvin
Marguerite Irvin
JBJohn N. Booth
John N. Booth
DSDaichi Shimbo
Daichi Shimbo
DLDaniel T. Lackland
Daniel T. Lackland
SOSuzanne Oparil
Suzanne Oparil
DCDavid A. Calhoun
David A. Calhoun

1 August 2017 in Hypertension
Verified
Journal Article
Closed access
PDF file
JBJohn N. Booth
John N. Booth
JLJiexiang Li
Jiexiang Li
LZLu Zhang
Lu Zhang
LCLiwei Chen
Liwei Chen
PMPaul Muntner
Paul Muntner
BEBrent Egan
Brent Egan
Prehypertension is associated with increased risk for hypertension and cardiovascular disease. Data are limited on the temporal changes in the prevalence of prehypertension and risk factors for hypertension and cardiovascular disease among US adults with prehypertension. We analyzed data from 30 958 US adults ≥20 years of age who participated in the National Health and Nutrition Examination Surveys between 1999 and 2012. Using the mean of 3 blood pressure (BP) measurements from a study examination, prehypertension was defined as systolic BP of 120 to 139 mm Hg and diastolic BP <90 mm Hg or diastolic BP of 80 to 89 mm Hg and systolic BP <140 mm Hg among participants not taking antihypertensive medication. Between 1999–2000 and 2011–2012, the percentage of US adults with prehypertension decreased from 31.2% to 28.2% ( P trend=0.007). During this time period, the prevalence of several risk factors for cardiovascular disease and incident hypertension increased among US adults with prehypertension, including prediabetes (9.6% to 21.6%), diabetes mellitus (6.0% to 8.5%), overweight (33.5% to 37.3%), and obesity (30.6% to 35.2%). There was a nonstatistically significant increase in no weekly leisure-time physical activity (40.0% to 43.9%). Also, the prevalence of adhering to the Dietary Approaches to Stop Hypertension eating pattern decreased (18.4% to 11.9%). In contrast, there was a nonstatistically significant decline in current smoking (25.9% to 23.2%). In conclusion, the prevalence of prehypertension has decreased modestly since 1999–2000. Population-level approaches directed at adults with prehypertension are needed to improve risk factors to prevent hypertension and cardiovascular disease.

1 July 2012 in SLEEP
Verified
Journal Article
Closed access
LBLindsay E. Bromley
Lindsay E. Bromley
JBJohn N. Booth
John N. Booth
JKJennifer M. Kilkus
Jennifer M. Kilkus
JIJacqueline G. Imperial
Jacqueline G. Imperial
PPPlamen D. Penev
Plamen D. Penev
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

1 June 2014 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JBJohn N. Booth
John N. Booth
ELEmily B. Levitan
Emily B. Levitan
TBTodd M. Brown
Todd M. Brown
MFMichael E. Farkouh
Michael E. Farkouh
MSMonika M. Safford
Monika M. Safford
PMPaul Muntner
Paul Muntner

3 December 2020 in Circulation
Verified
Journal Article
Closed access
PDF file
MSMonika M. Safford
Monika M. Safford
EREvgeniya Reshetnyak
Evgeniya Reshetnyak
MSMadeline R. Sterling
Madeline R. Sterling
JRJoshua S. Richman
Joshua S. Richman
PMPaul M. Muntner
Paul M. Muntner
LPLaura C. Pinheiro
Laura C. Pinheiro
Background: Social determinants of health (SDH) are individually associated with incident coronary heart disease (CHD) events. Indices reflecting social deprivation have been developed for population management, but are difficult to operationalize during clinical care. We examined whether a simple count of SDH is associated with fatal incident CHD and nonfatal myocardial infarction (MI). Methods: We used data from the prospective longitudinal REasons for Geographic And Racial Differences in Stroke cohort study, a national population-based sample of community-dwelling Black and white adults age ≥45 years recruited from 2003-7. Seven SDH from the five Healthy People 2020 domains included social context (Black race, social isolation); education (educational attainment); economic stability (annual household income); neighborhood (living in a zip code with high poverty); and healthcare (lacking health insurance, living in one of the 9 US states with the least public health infrastructure). Outcomes were expert adjudicated fatal incident CHD and nonfatal MI. Results: Of 22,152 participants free of CHD at baseline, 58.8% were women, 42.0% were Blacks, 20.6% had no SDH, 30.6% had 1, 23.0% had 2, and 25.8% had ≥3. There were 463 fatal incident CHD events and 932 nonfatal MIs over median 10.7 years [IQR 6.6-12.7]. Fewer SDH were associated with nonfatal MI than with fatal incident CHD. The age-adjusted incidence per 1000 person-years increased with the number of SDH for both fatal incident CHD (0 SDH 1.30, 1 SDH 1.44, 2 SDH 2.05, ≥3 SDH 2.86) and nonfatal MI (0 SDH 3.91, 1 SDH 4.33, ≥2 SDH 5.44). Compared to those without SDH, crude and fully adjusted hazard ratios (HR) for fatal incident CHD among those with ≥3 SDH were 3.00 (95% CI 2.17, 4.15) and 1.67 (95% CI 1.18, 2.37), respectively; and that for nonfatal MI among those with ≥2 SDH were 1.57 (95% CI 1.30, 1.90) and 1.14 (0.93, 1.41), respectively. Conclusions: A greater burden of SDH was associated with a graded increase in risk of incident CHD, with greater magnitude and independent associations for fatal incident CHD. Counting the number of SDH may be a promising approach that could be incorporated into clinical care to identify individuals at high risk of CHD.